Cyclerion is focused on developing systemic sGC stimulators for rare kidney diseases and cardiovascular conditions, with a strategic emphasis on licensing and collaboration opportunities in the biotech sector
Cyclerion is focused on developing systemic sGC stimulators for rare kidney diseases and cardiovascular conditions, with a strategic emphasis on licensing and collaboration opportunities in the biotech sector.